News about "Acesion Pharma "

Quotient and Acesion Partner on AI-Enhanced Formulation Development

Quotient and Acesion Partner on AI-Enhanced Formulation Development

Quotient Sciences and Acesion Pharma have partnered on AI-enhanced formulation development to accelerate early clinical decisions for atrial fibrillation treatments.

Acesion Pharma | 05/10/2026 | By News Bureau |  126

Acesion Pharma Begins Phase-II Trial of AP31969 in Atrial Fibrillation

Acesion Pharma Begins Phase-II Trial of AP31969 in Atrial Fibrillation

The Phase-II study of AP31969 by Acesion Pharma will evaluate the efficacy and safety of AP31969, a first-in-class oral SK ion channel inhibitor, in reducing atrial fibrillation burden using continuous cardiac rhythm monitoring.

Acesion Pharma | 08/01/2026 | By News Bureau |  304


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members